Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Lymphocytic Leukemia(CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003289
What this trial is testing

UCN-01 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT01556776
What this trial is testing

Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 89
Testing effectiveness (Phase 2)Study completedNCT02362035
What this trial is testing

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Who this might be right for
Follicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more
Acerta Pharma BV 161
Not applicableLooking for participantsNCT06299540
What this trial is testing

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Cilag S.A.S. 180
Not applicableStudy completedNCT04858568
What this trial is testing

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Who this might be right for
Classical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more
University Hospital Southampton NHS Foundation Trust 592
Not applicableEnded earlyNCT00594308
What this trial is testing

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Indiana University 10
Testing effectiveness (Phase 2)UnknownNCT02846584
What this trial is testing

A Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLeukemia, Lymphocytic, Chronic, B-CellLymphoma，Malignant
Southwest Hospital, China 100
Not applicableLooking for participantsNCT05326308
What this trial is testing

Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

Who this might be right for
Waldenström's MacroglobulinemiaChronic Lymphocytic LeukemiaMarginal Zone Lymphoma+1 more
iOMEDICO AG 845
Testing effectiveness (Phase 2)Study completedNCT02983617
What this trial is testing

Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 36
Early research (Phase 1)WithdrawnNCT00968461
What this trial is testing

Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders

Who this might be right for
LeukemiaLymphoproliferative Disorders
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06834529
What this trial is testing

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

Who this might be right for
Relapsed or Refractory B Cell Leukemia and Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences 20
Testing effectiveness (Phase 2)Study completedNCT00285103
What this trial is testing

SPC2996 in Chronic Lymphocytic Leukaemia

Who this might be right for
Chronic Lymphocytic Leukemia
Santaris Pharma A/S 46
Large-scale testing (Phase 3)Study completedNCT03406156
What this trial is testing

A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
AbbVie 120
Testing effectiveness (Phase 2)Ended earlyNCT02258529
What this trial is testing

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Who this might be right for
Follicular LymphomaSmall Lymphocytic Lymphoma
Gilead Sciences 10
Not applicableNot Yet RecruitingNCT07759661
What this trial is testing

Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Splenic Marginal Zone LymphomaHairy Cell Leukemia (HCL)
IRCCS San Raffaele 64
Not applicableEnded earlyNCT00965861
What this trial is testing

SCRI Tissue Testing Registry

Who this might be right for
MelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more
SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03534323
What this trial is testing

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

Who this might be right for
Chronic Lymphocytic LeukemiaRichter Syndrome
Dana-Farber Cancer Institute 55
Early research (Phase 1)Ended earlyNCT04804254
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers

Who this might be right for
B-cell Lymphoma
AbbVie 5
Testing effectiveness (Phase 2)Study completedNCT00738829
What this trial is testing

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Arbeitsgemeinschaft medikamentoese Tumortherapie 45
Testing effectiveness (Phase 2)Study completedNCT01011894
What this trial is testing

Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age

Who this might be right for
Chronic Lymphocytic LeukemiaLeukemia
Memorial Sloan Kettering Cancer Center 26
Next Page